Navigating Placebo Control Arms in Rare Disease Clinical Trials
- Weighing the pros and cons of placebo versus historical controls in small patient populations
- Understanding evolving regulatory guidance and recent approvals granted without control arms
- Addressing competitive pressures and leveraging shared natural history studies to strengthen trial design